跳至主要内容
临床试验/CTRI/2017/12/010805
CTRI/2017/12/010805招募中不适用

Definitive Volumetric Modulated Arc Therapy(VMAT) for Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Clinical Outcomes and Toxicity Analysis

Kasturba Hospital Manipal1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年9月13日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
To report the loco-regional control (LRC) rate of locally advanced laryngeal and hypopharyngeal cancers treated using definitive VMAT (+ chemotherapy)

研究概览

简要总结

Our objectives of this study are to document the loco-regional control rate and the

incidence of acute and late toxicities with definitive VMAT (+ chemotherapy) in locally

advanced laryngeal and hypopharyngeal cancers. With our analysis we hope to add to the

body of knowledge pertaining to the treatment of laryngeal and hypopharyngeal cancers

using the VMAT technique.

研究设计

研究类型
Observational

入排标准

年龄范围
25.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patients with hypopharyngeal and laryngeal SCC (except T1N0 and T2N0 Glottic cancers), Stages III – IV (AJCC) treated with definitive VMAT.

排除标准

  • Patients with laryngeal and hypopharyngeal tumors with histology other than SCC
  • Patients with Stage I/II tumors
  • Patients with distant metastasis
  • Patients undergoing upfront laryngectomy
  • Initial Karnofsky Performance Status (KPS) less than 60%.

结局指标

主要结局

To report the loco-regional control (LRC) rate of locally advanced laryngeal and hypopharyngeal cancers treated using definitive VMAT (+ chemotherapy)

时间窗: Assessment at 3 monthly intervals

次要结局

  • 1. To report the median laryngectomy free survival on follow-up(2. To report the median distant metastasis free survival on follow-up)

研究者

发起方
Kasturba Hospital Manipal
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验